Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF IssuersFidelityFMED
FMED

Fidelity Disruptive Medicine ETF

The FMED Exchange Traded Fund (ETF) is provided by Fidelity. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$31.00
+$0.16 (+0.52%) 2 days ago
1:30 PM 09/11/26 Closed
1D price range
$30.99$31.18
52W price range
$23.48$32.89
YTD Perf.
+14.16%
YTD Flows
Annualized volatility
Fund AuM
€43M
Share class AuM
€43M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US3160921470
TER
0.5%
Inception date
6/12/2023
Issuer
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Sep 11, 2026
-10%0%10%20%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
100.00%
Latest FMED news

No content available for this fund

FAQ about FMED

FMED is a Active ETF. This ETF provides exposure to Other Equities.
FMED carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.
FMED was introduced to the market on June 12, 2023. It trades on United States
Fidelity Disruptive Medicine ETF, FMED, is provided by Fidelity. Learn more about Fidelity here.
FMED oversees €43M in assets as of September 11, 2026.
FMED follows a distributing dividend policy, meaning it pays out income to investors.
As of July 31, 2026, FMED has significant geographic allocations in USA, Netherlands and United Kingdom.
As of July 31, 2026, FMED focuses largely on Healthcare.
As of July 31, 2026, FMED holds 74 positions in its portfolio, with 43.09% of assets concentrated in its top 15 holdings.
As of July 31, 2026, FMED top three holdings include 10X Genomics, Inc., Thermo Fisher Scientific, Inc. and Danaher Corp..
The base currency of FMED is USD.
Data as of 07/31/26
10X Genomics, Inc.
4.48%
Thermo Fisher Scientific, Inc.
3.98%
Danaher Corp.
3.86%
Lifestance Health Group, Inc.
3.15%
Alnylam Pharmaceuticals, Inc.
3.10%
argenx SE
2.99%
Cogent Biosciences, Inc.
2.98%
Revolution Medicines, Inc.
2.85%
Illumina, Inc.
2.62%
Intuitive Surgical, Inc.
2.34%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight